Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) [External links]
Download this slide deck for information on KEYNOTE 048.
More information about KEYTRUDA® (pembrolizumab) in first-line Head & Neck Squamous Cell Carcinoma:
Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland)
By clicking the links above you will leave the MSD Connect website and be taken to the emc PI portal website
GB-OHN-00172 | Date of Preparation: June 2020